Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Find out effective ways to build wealth without investing, utilizing smart financial habits. Start growing your wealth without the risks.
22,750 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A new CBO forecast warns that social security’s trust fund could be empty by 2032, triggering automatic cuts that wou...
Unlock the meaning behind the natr 2026 earnings transcript. Learn how to parse numbers, gauge management guidance, a...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...
A year of unprecedented cyber thefts saw North Korean-linked groups drain more than $2 billion from financial network...
Bridgewater founder Ray Dalio warns that China’s ascent is shifting global power and investor risk. The commentary co...
Coinbase warns possible weekend disruptions as it schedules a brief system upgrade for Saturday. Traders should expec...
A leading hedge fund shocks markets with a major pivot into AI infrastructure, prioritizing hardware, energy-ready da...
A Deloitte-recognized fastest-growing software firm opens the last phase of a pre-IPO funding round, offering micro-s...
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...
Investors are weighing Micron's AI-driven demand against a volatile memory market. This guide breaks down whether you...
Broadcom posted solid revenue growth and a solid EPS beat, but AI chip guidance disappointed some. This guide breaks ...